Treatment effects may remain the same even when trial participants differed from the target population
- 10 May 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Clinical Epidemiology
- Vol. 124, 126-138
- https://doi.org/10.1016/j.jclinepi.2020.05.001
Abstract
No abstract availableThis publication has 64 references indexed in Scilit:
- Weight Trimming and Propensity Score WeightingPLOS ONE, 2011
- Generalizing Evidence From Randomized Clinical Trials to Target Populations: The ACTG 320 TrialAmerican Journal of Epidemiology, 2010
- Reasons for participating in randomised controlled trials: conditional altruism and considerations for selfTrials, 2010
- A method of identifying and correcting miscoding, misclassification and misdiagnosis in diabetes: a pilot and validation study of routinely collected dataDiabetic Medicine, 2010
- Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samplesStatistics in Medicine, 2009
- Power for tests of interaction: effect of raising the Type I error rateEpidemiologic Perspectives & Innovations, 2007
- External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?Thorax, 2007
- Factors That Can Affect the External Validity of Randomised Controlled TrialsPLoS Clinical Trials, 2006
- The central role of the propensity score in observational studies for causal effectsBiometrika, 1983